These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 33559134)
1. Complementary effects of pine bark extract supplementation on inattention, impulsivity, and antioxidative status in children with attention-deficit hyperactivity disorder: A double-blinded randomized placebo-controlled cross-over study. Hsu CD; Hsieh LH; Chen YL; Lin IC; Chen YR; Chen CC; Shirakawa H; Yang SC Phytother Res; 2021 Jun; 35(6):3226-3235. PubMed ID: 33559134 [TBL] [Abstract][Full Text] [Related]
2. Reduced inattention and hyperactivity and improved cognition after marine oil extract (PCSO-524®) supplementation in children and adolescents with clinical and subclinical symptoms of attention-deficit hyperactivity disorder (ADHD): a randomised, double-blind, placebo-controlled trial. Kean JD; Sarris J; Scholey A; Silberstein R; Downey LA; Stough C Psychopharmacology (Berl); 2017 Feb; 234(3):403-420. PubMed ID: 27921139 [TBL] [Abstract][Full Text] [Related]
3. The effect of polyphenolic extract from pine bark, Pycnogenol on the level of glutathione in children suffering from attention deficit hyperactivity disorder (ADHD). Dvoráková M; Sivonová M; Trebatická J; Skodácek I; Waczuliková I; Muchová J; Duracková Z Redox Rep; 2006; 11(4):163-72. PubMed ID: 16984739 [TBL] [Abstract][Full Text] [Related]
4. Urinary catecholamines in children with attention deficit hyperactivity disorder (ADHD): modulation by a polyphenolic extract from pine bark (pycnogenol). Dvoráková M; Jezová D; Blazícek P; Trebatická J; Skodácek I; Suba J; Iveta W; Rohdewald P; Duracková Z Nutr Neurosci; 2007; 10(3-4):151-7. PubMed ID: 18019397 [TBL] [Abstract][Full Text] [Related]
5. Effects of Korean red ginseng extract on behavior in children with symptoms of inattention and hyperactivity/impulsivity: a double-blind randomized placebo-controlled trial. Ko HJ; Kim I; Kim JB; Moon Y; Whang MC; Lee KM; Jung SP J Child Adolesc Psychopharmacol; 2014 Nov; 24(9):501-8. PubMed ID: 25369174 [TBL] [Abstract][Full Text] [Related]
6. The effect of phosphatidylserine administration on memory and symptoms of attention-deficit hyperactivity disorder: a randomised, double-blind, placebo-controlled clinical trial. Hirayama S; Terasawa K; Rabeler R; Hirayama T; Inoue T; Tatsumi Y; Purpura M; Jäger R J Hum Nutr Diet; 2014 Apr; 27 Suppl 2():284-91. PubMed ID: 23495677 [TBL] [Abstract][Full Text] [Related]
7. Inattention and hyperactivity/impulsivity among children with attention-deficit/hyperactivity-disorder, autism spectrum disorder, and intellectual disability. McClain MB; Hasty Mills AM; Murphy LE Res Dev Disabil; 2017 Nov; 70():175-184. PubMed ID: 28957735 [TBL] [Abstract][Full Text] [Related]
8. Resveratrol adjunct to methylphenidate improves symptoms of attention-deficit/hyperactivity disorder: a randomized, double-blinded, placebo-controlled clinical trial. Rafeiy-Torghabeh M; Ashraf-Ganjouei A; Moradi K; Bagheri S; Mohammadi MR; Akhondzadeh S Eur Child Adolesc Psychiatry; 2021 May; 30(5):799-807. PubMed ID: 32449130 [TBL] [Abstract][Full Text] [Related]
9. Effect of polyphenolic extract, Pycnogenol, on the level of 8-oxoguanine in children suffering from attention deficit/hyperactivity disorder. Chovanová Z; Muchová J; Sivonová M; Dvoráková M; Zitnanová I; Waczulíková I; Trebatická J; Skodácek I; Duracková Z Free Radic Res; 2006 Sep; 40(9):1003-10. PubMed ID: 17015282 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study. Biederman J; Swanson JM; Wigal SB; Kratochvil CJ; Boellner SW; Earl CQ; Jiang J; Greenhill L Pediatrics; 2005 Dec; 116(6):e777-84. PubMed ID: 16322134 [TBL] [Abstract][Full Text] [Related]
11. The Effect of Experimental Supplementation with the Klamath Algae Extract Klamin on Attention-Deficit/Hyperactivity Disorder. Cremonte M; Sisti D; Maraucci I; Giribone S; Colombo E; Rocchi MBL; Scoglio S J Med Food; 2017 Dec; 20(12):1233-1239. PubMed ID: 29116873 [TBL] [Abstract][Full Text] [Related]
12. Behavioral and cognitive effects of docosahexaenoic acid in drug-naïve children with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled clinical trial. Crippa A; Tesei A; Sangiorgio F; Salandi A; Trabattoni S; Grazioli S; Agostoni C; Molteni M; Nobile M Eur Child Adolesc Psychiatry; 2019 Apr; 28(4):571-583. PubMed ID: 30246216 [TBL] [Abstract][Full Text] [Related]
13. Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial [ISRCTN64132371]. Akhondzadeh S; Mohammadi MR; Khademi M BMC Psychiatry; 2004 Apr; 4():9. PubMed ID: 15070418 [TBL] [Abstract][Full Text] [Related]
14. Reduced Symptoms of Inattention after Dietary Omega-3 Fatty Acid Supplementation in Boys with and without Attention Deficit/Hyperactivity Disorder. Bos DJ; Oranje B; Veerhoek ES; Van Diepen RM; Weusten JM; Demmelmair H; Koletzko B; de Sain-van der Velden MG; Eilander A; Hoeksma M; Durston S Neuropsychopharmacology; 2015 Sep; 40(10):2298-306. PubMed ID: 25790022 [TBL] [Abstract][Full Text] [Related]
15. High pretreatment cognitive impulsivity predicts response of oppositional symptoms to methylphenidate in patients with attention-deficit hyperactivity disorder/oppositional defiant disorder. Golubchik P; Shalev L; Tsamir D; Manor I; Weizman A Int Clin Psychopharmacol; 2019 May; 34(3):138-142. PubMed ID: 30640748 [TBL] [Abstract][Full Text] [Related]
16. The Effects of Long-Acting Stimulant and Nonstimulant Medications in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Meta-Analysis of Randomized Controlled Trials. Cerrillo-Urbina AJ; García-Hermoso A; Pardo-Guijarro MJ; Sánchez-López M; Santos-Gómez JL; Martínez-Vizcaíno V J Child Adolesc Psychopharmacol; 2018 Oct; 28(8):494-507. PubMed ID: 29897263 [TBL] [Abstract][Full Text] [Related]
17. Behavioral effects of liothyronine (L-T3) in children with attention deficit hyperactivity disorder in the presence and absence of resistance to thyroid hormone. Weiss RE; Stein MA; Refetoff S Thyroid; 1997 Jun; 7(3):389-93. PubMed ID: 9226208 [TBL] [Abstract][Full Text] [Related]
18. A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder. Voigt RG; Llorente AM; Jensen CL; Fraley JK; Berretta MC; Heird WC J Pediatr; 2001 Aug; 139(2):189-96. PubMed ID: 11487742 [TBL] [Abstract][Full Text] [Related]
19. An open-label study to elucidate the effects of standardized Bacopa monnieri extract in the management of symptoms of attention-deficit hyperactivity disorder in children. Dave UP; Dingankar SR; Saxena VS; Joseph JA; Bethapudi B; Agarwal A; Kudiganti V Adv Mind Body Med; 2014; 28(2):10-5. PubMed ID: 24682000 [TBL] [Abstract][Full Text] [Related]
20. Hyperactivity and impulsivity in children with untreated allergic rhinitis: corroborated by rating scale and continuous performance test. Yang MT; Lee WT; Liang JS; Lin YJ; Fu WM; Chen CC Pediatr Neonatol; 2014 Jun; 55(3):168-74. PubMed ID: 24211085 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]